Events Speakers Talks
 

Speakers

Sort by
Newest
Trending
1-30 of 49
1-30 of 49
Filter
Colby Watkins
COO at WherezHemp
absorption (pharmacology), alternative medicine, amazon (company), anti-inflammatory, anti-predator adaptation, appetite, aromatherapy, audit, bank, behavior, blog, blood alcohol content, book, botany, brand, brand loyalty, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, chemical substance, coffee, coffee bean, coffeehouse, communication, communication protocol, community, competition, customer relationship management, dose (biochemistry), drink, due diligence, email, email spam, emerging market, entourage effect, essential oil, facebook, food, food and drug administration, globalization, gluten-free diet, good manufacturing practice, google, hemp, herbal distillate, hindsight bias, insurance, juice, lemon, ligand (biochemistry), limonene, linkedin, mango, margin of error, medication, nsf international, nutraceutical, opt-in email, organic certification, pain, peer-to-peer, price, reason, red bull, regulatory compliance, risk management, sales, sales process engineering, secondary metabolite, social media, software , solvent, spectrum, starbucks, target corporation, telecommuting, terpene, terpenoid, tetrahydrocannabinol, trade, walmart, water, water activity, youtube
Michael Flemmens
VP of Technical Business Development at SōRSE Technology
absorption (pharmacology), alternative medicine, anti-predator adaptation, appetite, attention, blinded experiment, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis industry, chemical substance, clinicaltrials.gov, coffee, coffee bean, coffeehouse, coronavirus disease 2019, diesel fuel, distillation, dose (biochemistry), food, food and drug administration, hospital, ibuprofen, in vitro, innovation, laboratory, ligand (biochemistry), medication, molecule, nutraceutical, pain, pharmaceutical industry, pharmacokinetics, randomized controlled trial, red bull, solvent, starbucks, steam distillation, supercritical fluid, tetrahydrocannabinol, women's health
Austin Rhodus
Director Of Membership Services at Midwest Hemp Council
absorption (pharmacology), alternative medicine, anti-predator adaptation, appetite, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, dose (biochemistry), food, ligand (biochemistry), medication, nutraceutical, pain, red bull, solvent, starbucks, tetrahydrocannabinol
Blair Curless
Clinical Pharmacist at Phoebe Putney Health System
absorption (pharmacology), advertising, analgesic, anti-inflammatory, aphria (company), bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, class action, coffee, cosmetics, damages, dietary supplement, distribution (marketing), doctor of pharmacy, dose (biochemistry), drug, euphoria, false advertising, federal trade commission, flavor, food, food and drug administration, hemp, interleukin 17, kool-aid, law, lawsuit, ligand (biochemistry), marketplace, medical cannabis, medication, mountain dew, nestea, new drug application, nonsteroidal anti-inflammatory drug, novel food, opioid, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, pricing, product testing, recycling, regulatory compliance, retail, route of administration, shelf life, social media, soft drink, sublingual administration, tea, tetrahydrocannabinol, tetrahydrocannabivarin, toast (honor), topical medication
Daniel Tobon
Chief Executive Officer / Director at iVIK Holdings Ltd
absorption (pharmacology), anti-inflammatory, anticoagulant, anticonvulsant, antidepressant, anxiolytic, benzodiazepine, brand, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis (drug), certificate of analysis, clinical trial, convertible bond, cosmetics, crowdfunding, cytochrome p450, debenture, debt, democratic party (united states), dietary supplement, discounting, dose (biochemistry), drug interaction, drug overdose, entourage effect, financial capital, food and drug administration, geriatrics, gerrymandering, grapefruit–drug interactions, health claim, interest, interest rate, investment, investor, major depressive disorder, mechanism of action, medical cannabis, medication, mergers and acquisitions, neuroplasticity, neurotransmitter, opioid, option (finance), organic certification, over-the-counter drug, oxycodone/paracetamol, pharmacology, pharmacy, post-traumatic stress disorder, prescription drug, prothrombin time, psilocybin, psilocybin mushroom, psychedelic drug, pulmonary embolism, retail, sense, serotonin, signal transduction, stock, stock dilution, stroke, swing state, tetrahydrocannabinol, therapeutic index, valuation (finance), warfarin
Charles Piermarini
CEO at Restorative CBD
absorption (pharmacology), adoption, allosteric regulation, anti-inflammatory, anticoagulant, anticonvulsant, antiviral drug, benzodiazepine, bioavailability, breathing, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), certificate of analysis, clinical trial, coronavirus disease 2019, cytochrome p450, dietary supplement, dose (biochemistry), drug, drug interaction, drug overdose, flax, geriatrics, grapefruit–drug interactions, infection, inhaler, insomnia, ligand (biochemistry), lung volumes, medical cannabis, medication, melatonin, nanotechnology, omega-3 fatty acid, omega-6 fatty acid, opioid, over-the-counter drug, oxycodone/paracetamol, pain, patient, pharmaceutical industry, pharmacology, pharmacy, prothrombin time, pulmonary embolism, risk, route of administration, sense, serotonin, serotonin syndrome, signal transduction, sleep disorder, stroke, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, warfarin
Najifa Choudhury
Ambulatory Care Pharmacist at PACE SEMI
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis (drug), cannabis edible, certificate of analysis, clinical trial, cytochrome p450, doctor of pharmacy, dose (biochemistry), drug interaction, drug overdose, euphoria, geriatrics, grapefruit–drug interactions, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, opioid, over-the-counter drug, oxycodone/paracetamol, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, prothrombin time, pulmonary embolism, route of administration, signal transduction, stroke, sublingual administration, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Cohin Kakar
Chief Marketing Officer at The Anthos Group
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, appetite, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, certificate of analysis, chemotherapy, clinical trial, cytochrome p450, dementia, doctor of pharmacy, dose (biochemistry), drug development, drug interaction, drug overdose, euphoria, fibromyalgia, food and drug administration, geriatrics, grapefruit–drug interactions, headache, inflammation, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, opioid epidemic in the united states, over-the-counter drug, oxycodone/paracetamol, personalized medicine, pharmaceutical formulation, pharmacogenomics, pharmacology, pharmacy, pharmacy school, placebo, prothrombin time, pulmonary embolism, route of administration, sensitivity and specificity, signal transduction, stroke, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Lola O Ohonba
Certified Medical Cannabist Specialist at WCI Health
absorption (pharmacology), alternative medicine, analgesic, anti-inflammatory, anti-predator adaptation, antidepressant, anxiolytic, appetite, bioavailability, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, democratic party (united states), doctor of pharmacy, dose (biochemistry), entourage effect, euphoria, food, food and drug administration, gerrymandering, interleukin 17, ligand (biochemistry), major depressive disorder, mechanism of action, medical cannabis, medication, neuroplasticity, neurotransmitter, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pain, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, red bull, route of administration, sense, serotonin, solvent, starbucks, sublingual administration, swing state, tetrahydrocannabinol, tetrahydrocannabivarin, topical medication
Joseph Friedman
Consultant, National Speaker, Medical Cannabis Pharmacist
absorption (pharmacology), analgesic, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis strain, clinical trial, delta-8-tetrahydrocannabinol, doctor of pharmacy, dose (biochemistry), euphoria, first pass effect, high-performance liquid chromatography, institutional review board, interleukin 17, ligand (biochemistry), lipophilicity, mass spectrometry, medication, natural product, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pharmaceutical formulation, pharmacokinetics, pharmacology, pharmacy, pharmacy school, route of administration, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, topical medication, waters corporation
Rick Sanders
Technical Sales at Thar Process: FDA Registered Extraction / Purification Services & Equipment: SFE + SFC (CE, UL, CSA)
bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis indica, cannabis sativa, cannabis strain, chromatography, drug test, entourage effect, environmental remediation, ethanol, fertilizer, freeze-drying, hexane, high-performance liquid chromatography, isopropyl alcohol, solution, supercritical carbon dioxide, supercritical fluid, tetrahydrocannabinol, water
Jourdan Woltz
Owner at JADE Healing Co CBD
antidepressant, autism, belief, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis indica, cannabis sativa, cannabis strain, chromatography, dose (biochemistry), dronabinol, drug test, entourage effect, environmental remediation, ethanol, fertilizer, freeze-drying, health care, hexane, high-performance liquid chromatography, isopropyl alcohol, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, solution, substance dependence, supercritical carbon dioxide, supercritical fluid, tetrahydrocannabinol, treatment-resistant depression, water
Jokūbas Žiburkus
CEO and Co-Founder at Adendox
allosteric modulator, allosteric regulation, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis indica, cytokine, endocannabinoid system, glutamate (neurotransmitter), hashish, hippocampus, inflammation, medical cannabis, nervous system, neuron, neuroprotection, neuroscience, receptor antagonist, synapse, tetrahydrocannabinol, tetrahydrocannabinolic acid
Israel Garcia
Director Of Chemistry at Bayou City Hemp Company
bioavailability, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, emulsion, endocannabinoid system, food and drug administration, health, human, ibuprofen, memory, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, route of administration, shelf life, sleep, solution, tablet (pharmacy), tetrahydrocannabinol, transparency and translucency
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Stephen Horton
Director Of Operations at Bayou City Hemp Company
bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis indica, cannabis sativa, cannabis strain, chromatography, drug test, entourage effect, environmental remediation, ethanol, fertilizer, freeze-drying, hexane, high-performance liquid chromatography, isopropyl alcohol, solution, supercritical carbon dioxide, supercritical fluid, tetrahydrocannabinol, water
Mike Sandoval
President at Sante Laboratories
accuracy and precision, analytical chemistry, aspergillosis, bank, bioavailability, brand, breakfast, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemical substance, chemistry, competition, consumer protection, conversation, crystallization, cytochrome p450, diclofenac, dietary supplement, distillation, dose (biochemistry), dream, drug development, due diligence, electronic cigarette, emulsion, endocannabinoid system, experiment, expert, expungement, food and drug administration, frosted mini-wheats, health, human, humidity, ibuprofen, immunodeficiency, infection, information, insurance, investor, laboratory, loan, market (economics), medical cannabis, memory, mold, money, mycotoxin, occupational safety and health, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, ph meter, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, reason, regulatory compliance, route of administration, safety, scientific method, sesame, shelf life, sleep, solution, stove, tablet (pharmacy), technology, temperature, tetrahydrocannabinol, the matrix, traceability, tractor, transparency and translucency, treaty, understanding
Carl Sheeler
Co-Founder at Two Bears Farm
behavior, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), charlotte's web (cannabis), commodity, dietary supplement, dose (biochemistry), electronic cigarette, entourage effect, farmer, fda warning letter, flavonoid, food and drug administration, genetically modified food, hemp, herbicide, insomnia, lemon, medical cannabis, medication, nsf international, organic certification, pain, pharmaceutical industry, polypharmacy, price, reason, scientific method, solution, terpene, tetrahydrocannabinol, tobacco, toxicity, understanding, warren buffett, water
Josh Pearl
Founder and Chief Scientist at Gruene Cross Health and Wellness
behavior, brand, california, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), certificate of analysis, commodity, counterfeit consumer goods, dose (biochemistry), electronic cigarette, entourage effect, farmer, fertilizer, genetically modified food, health care, hemp, herbicide, insomnia, nothing, nsf international, organic certification, organic farming, overtime, packaging and labeling, packaging, and labeling, pain, patient, pharmaceutical industry, plastic, price, retail, shelf life, solution, supply chain, tetrahydrocannabinol, titanium, tobacco, traceability, vaporizer (inhalation device), warren buffett, water content
Peter Holzworth
Global Expansion Officer & Chief Revenue Officer at Green Horizon (CA) & Red Vault Extractions
alzheimer's disease, amazon (company), audit, barcode, behavior, bioavailability, brand, brand loyalty, candy, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis indica, cannabis sativa, cannabis strain, certification, chernobyl disaster, chinese cuisine, commodity, communication protocol, convertible bond, corporation, cosmetics, crowdfunding, debenture, debt, dietary supplement, discounting, discrimination, dose (biochemistry), drug test, due diligence, electronic cigarette, employment, entourage effect, farm-to-table, farmer, fda warning letter, federal food, drug, and cosmetic act, federal trade commission, financial capital, food and drug administration, food safety, fraud, generally recognized as safe, genetically modified food, globalization, gluten-free diet, good manufacturing practice, gummy candy, health claim, hemp, herbicide, hybrid (biology), industry, insomnia, insurance, intellectual property, interest, interest rate, investment, investor, kashrut, margin of error, medical cannabis, mergers and acquisitions, nsf international, nutraceutical, nutrition facts label, option (finance), organic certification, over-the-counter drug, pain, patent, pesticide, pharmaceutical industry, pharmacy, prescription drug, price, property, reason, regulation of food and dietary supplements by the u.s. food and drug administration, regulatory compliance, retail, risk management, sales, shampoo, sleep, social media, software , software patent, soil, solution, startup company, stock, stock dilution, supply chain, target corporation, target market, taste, tennessee, tetrahydrocannabinol, tobacco, trial, truck driver, valuation (finance), vitamin, walmart, warren buffett
George Hou
CEO at Ingenuity Beverages
alzheimer's disease, audit, background check, bank, behavior, best practice, board certification, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis sativa, central processing unit, chinese cuisine, commerce clause, commodity, controlled substances act, cosmetics, craft brewery and microbrewery, dietary supplement, dose (biochemistry), due diligence, electronic cigarette, entourage effect, farm-to-table, farmer, fda food safety modernization act, food, food and drug administration, food safety, foodborne illness, genetically modified food, good manufacturing practice, gummy candy, health claim, hemp, hemp oil, herbicide, ibuprofen, insomnia, iso 9000, lobbying, medical cannabis, medication, mind, nsf international, nutraceutical, organic certification, over-the-counter drug, pain, pathology, pharmacy, prescription drug, price, quality management system, regulation of food and dietary supplements by the u.s. food and drug administration, regulatory compliance, safety, sleep, social media, solution, startup company, target market, taste, tetrahydrocannabinol, tetrahydrocannabinol acid, tobacco, verification and validation, warren buffett
Lynn Marie Morski
Medical Director at WayofLeaf
adoption, behavior, bioavailability, brand, breathing, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), commodity, dietary supplement, dose (biochemistry), drug, electronic cigarette, entourage effect, farmer, genetically modified food, hemp, herbicide, inhaler, insomnia, lung volumes, medical cannabis, medication, nanotechnology, nsf international, organic certification, pain, patient, pharmaceutical industry, price, risk, route of administration, serotonin, serotonin syndrome, solution, terpene, tetrahydrocannabinol, tobacco, warren buffett
Daniel Sliva
CSO & Founder at DSTest Laboratories
allosteric regulation, anti-inflammatory, antiviral drug, aspirin, assay, attention, bioavailability, biology, blinded experiment, book, bootleg recording, brand, brand loyalty, breast cancer, cancer, cannabidiol, cannabidiol is, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cardiovascular disease, cell signaling, chemical substance, chemistry, chromatography, chronic pain, cigarette, clinical trial, clinicaltrials.gov, coffee, coffee bean, common sense, coronavirus disease 2019, crisis management, diesel fuel, dietary supplement, direct-to-consumer advertising, distillation, dose (biochemistry), drug, drug test, end-user, endocannabinoid system, experiment, first, pass effect, flax, food, food and drug administration, fraud, gastrointestinal tract, germination, good manufacturing practice, green tea, hemp, hepatotoxicity, high-performance liquid chromatography, hospital, ibuprofen, in vitro, infection, inflammation, innovation, insomnia, intravenous therapy, iso/iec 17025, knowledge, laboratory, ligand (biochemistry), lipid, marketplace, medication, melatonin, micro-encapsulation, mining, molecule, nabiximols, nanoparticle, national institutes of health, nutraceutical, occupational safety and health, omega-3 fatty acid, omega-6 fatty acid, organ transplantation, osteoarthritis, packaging and labeling, pain, paracetamol, peripheral neuropathy, petroleum, pharmaceutical industry, pharmacokinetics, pharmacology, psychoactive drug, randomized controlled trial, reason, receptor (biochemistry), recycling, reliability engineering, research, right to know, risk, route of administration, sense, serotonin, sleep disorder, social supports, steam distillation, steve jobs, supercritical fluid, taste, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, the end-user, thin-layer chromatography, toxicity, vitamin, warranty, waste, water, women's health
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
Kayla Fioravanti
Business Owner at Ology Essentials
aromatherapy, bank, big data, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis sativa, clinical trial, craft brewery and microbrewery, crop insurance, curriculum, customer, dose (biochemistry), evidence-based medicine, finance, food, food and drug administration, goal, herb, medical cannabis, medical prescription, medication, mirror, molecule, organized crime, pain management, payment, pharmaceutical industry, placebo, placebo-controlled study, prescription drug, scientific method, stress (biology), taste, tetrahydrocannabinol, thalidomide, water, whole foods market, wine, wood
Randy Fink
Physician, Medical Director at Miami Center of Excellence, LLC
alternative medicine, anesthesia, antihypertensive drug, anxiety, arm, aromatherapy, bank, bioidentical hormone replacement therapy, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, cannabis sativa, clinical trial, crohn's disease, crop insurance, curriculum, depression (mood), diarrhea, dose (biochemistry), endocannabinoid system, entourage effect, erection, evidence-based medicine, finance, food and drug administration, gastrointestinal disease, general surgery, gums, hemp, human sexual activity, ileostomy, inflammatory bowel disease, libido, medical cannabis, medical prescription, medication, mind, organized crime, orgasm, pain management, payment, pharmaceutical industry, pharmacology, pharmacy, placebo-controlled study, prescription drug, psychoactive drug, retail, route of administration, tadalafil, terminal illness, tetrahydrocannabinol, therapeutic index, transgender hormone therapy (male-to-female), ulcerative colitis
Allen Manison
Chief Science Officer at Noetic Nutraceuticals, LLC
adipose tissue, antidepressant, aromatherapy, arthritis, bank, brain damage, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), chronic condition, chronic pain, clinical trial, crop insurance, curriculum, dose (biochemistry), endocannabinoid system, evidence-based medicine, fibromyalgia, finance, food and drug administration, immune system, inflammation, lymphocyte, major depressive disorder, medical cannabis, medical prescription, medication, organized crime, pain disorder, pain management, payment, pharmaceutical industry, placebo-controlled study, prescription drug, psychotherapy, tetrahydrocannabinol, tetrahydrocannabinol acid
Carlton Bone
Founder at Upward Cannabis Kitchen
adolescence, alternative medicine, anesthesia, antibiotic, anticoagulant, anticonvulsant, antifungal, antihypertensive drug, appetite, aromatherapy, bank, bicycle, biotechnology, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, certificate of analysis, chemotherapy, clinical trial, concept, crohn's disease, crop insurance, curriculum, curveball, cvs pharmacy, dementia, depression (mood), diarrhea, dose (biochemistry), drink, drug development, endocannabinoid system, engineer, entourage effect, evidence-based medicine, family medicine, fibromyalgia, finance, food and drug administration, gastrointestinal disease, general surgery, good manufacturing practice, headache, ileostomy, inflammation, inflammatory bowel disease, market (economics), medical cannabis, medical prescription, medication, neurology, nutraceutical, opioid, opioid epidemic in the united states, organized crime, over-the-counter drug, pain management, payment, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, placebo-controlled study, prescription drug, psychoactive drug, race (human categorization), reverse engineering, route of administration, sense, sensitivity and specificity, slider (baseball), stroke, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, therapeutic index, thrombus, ulcerative colitis, washington (state)
Anna Schwabe
Cannabis Geneticist and Research Coordinator at Mile High Labs
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
1 2
1-30 of 49